Trine-Lise L.
- Country
- Norway
- Department
- Department of hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Hematologic Malignancies
The investigator concentrates on malignant blood disorders, addressing both acute and chronic entities.
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Chronic Lymphocytic Leukemia
- Diffuse Large B‑Cell Lymphoma
- Multiple Myeloma
Research includes targeted therapies, immunomodulatory agents, and novel combination regimens.
Solid Tumor Oncology
Work extends to major solid cancers, emphasizing precision medicine and immunotherapy.
- Breast Cancer
- Non‑Small Cell Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Bladder Cancer
- Melanoma
Efforts focus on molecular profiling, checkpoint inhibition, and resistance mechanisms.
Metabolic and Liver Disorders
Investigations target metabolic liver disease and related systemic conditions.
- Non‑Alcoholic Steatohepatitis
- Primary Sclerosing Cholangitis
- Primary Biliary Cholangitis
- Obesity
- Type 2 Diabetes Mellitus
Therapeutic focus includes antifibrotic agents and metabolic risk reduction.
Cardiovascular and Thrombotic Disease
Clinical work addresses atherosclerotic disease, arrhythmia‑related stroke risk, and coagulation.
- Atherosclerotic Cardiovascular Disease
- Atrial Fibrillation
- Ischemic Stroke
- Venous Thromboembolism
- Anticoagulation Therapy
Studies evaluate novel oral anticoagulants and risk‑adjusted prevention strategies.
Immune‑Mediated and Inflammatory Conditions
Research includes chronic inflammatory and autoimmune diseases with high unmet need.
- Inflammatory Bowel Disease
- Sarcoidosis
- Multiple Sclerosis
- Immune Thrombocytopenia
- Systemic Autoimmune Rheumatic Diseases
Efforts explore biologic modulation and disease‑modifying strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.